6-MP 50mg

About 6-MP 50mg

6-MP 50mg is used for the treatment of acute lymphoblastic leukemia and as a chemotherapy agent in certain solid tumor protocols, including ovarian cancer, head and neck cancer, and cervical cancer. Manufactured by Zydus Lifesciences, this medication contains Mercaptopurine 50mg, an antimetabolite that interferes with DNA and RNA synthesis, thereby inhibiting cancer cell growth and proliferation. Mercaptopurine has been a cornerstone in oncology protocols for decades, demonstrating efficacy in both hematologic malignancies and solid tumors when used as part of combination therapy regimens. Patients undergoing combination chemotherapy may also require supportive medications such as Atazor R Tablet (Atazanavir/Ritonavir) for concurrent conditions, and oncologists often prescribe 6-MP alongside other targeted therapies including Bosuvi 100mg (Bosutinib) depending on the specific cancer type and treatment protocol.

Dosage & Usage

How do I take 6-MP 50mg? The dosage must be individualized by your oncologist based on body surface area, treatment protocol, blood counts, and liver function. The typical starting dose ranges from 1.5 to 2.5 mg/kg body weight daily, though specific cancer protocols may vary significantly. Tablets should be taken on an empty stomach, either one hour before or two hours after meals, as food can reduce absorption. Swallow tablets whole with water without crushing or splitting. Regular blood tests are mandatory to monitor white blood cell counts, liver enzymes, and bone marrow function, as dose adjustments are frequently necessary based on these parameters. Never adjust your dose without oncologist guidance, and if you miss a dose, contact your healthcare provider immediately for instructions rather than doubling the next dose.

Who Is It For?

Is 6-MP 50mg safe for me? This medication is prescribed for adult and pediatric patients diagnosed with acute lymphoblastic leukemia or certain solid tumors where mercaptopurine is part of the established treatment protocol. It is not suitable for patients with known hypersensitivity to mercaptopurine or those with severe bone marrow suppression. Individuals with thiopurine methyltransferase (TPMT) deficiency require significant dose reduction or alternative therapy, as genetic testing often guides dosing decisions. Pregnant women should avoid this medication due to serious fetal risks, and effective contraception is mandatory during treatment. Patients with pre-existing liver disease require close monitoring, and those taking allopurinol must receive reduced mercaptopurine doses to prevent severe toxicity. Treatment protocols may combine 6-MP with other agents like Afanat 30mg (Afatinib Dimaleate) for specific cancer types, though your oncology team will determine the optimal regimen based on your diagnosis and overall health status.

Why Buy From SafeRxPills?

SafeRxPills is a fully licensed online pharmacy delivering critical life-saving medications to patients across Australia, the United Kingdom, the United States, and Canada. We understand the urgency of cancer treatment and provide discreet, temperature-controlled shipping within 7-14 business days to ensure medication integrity. Our pharmacy sources genuine Zydus Lifesciences products directly from certified manufacturers, with full traceability and pharmaceutical-grade storage standards. Whether you're in Sydney, London, New York, or Toronto, our dedicated oncology support team assists with prescription verification and coordinates with your healthcare providers to ensure seamless medication access. We maintain strict confidentiality protocols and provide secure packaging for all chemotherapy medications, recognizing the sensitive nature of cancer treatment and the importance of reliable medication supply throughout your therapy journey.